Drug ID: | NPD7879 |
Drug Name: | |
Molecular Formula: | C34H37FO15 |
Canonical SMILES: | COc1cccc2c1C(=O)c1c(O)c3[C@@H](O[C@@H]4O[C@@H](C)[C@H]([C@H]([C@H]4F)O)O)C[C@](Cc3c(c1C2=O)O)(O)C(=O)COC(=O)CCCCCC(=O)O |
Standard InCHI: | InChI=1S/C34H37FO15/c1-14-27(40)32(45)26(35)33(49-14)50-18-12-34(46,19(36)13-48-21(39)10-5-3-4-9-20(37)38)11-16-23(18)31(44)25-24(29(16)42)28(41)15-7-6-8-17(47-2)22(15)30(25)43/h6-8,14,18,26-27,32-33,40,42,44-46H,3-5,9-13H2,1-2H3,(H,37,38)/t14-,18-,26+,27+,32-,33-,34-/m0/s1 |
Standard InCHIKey: | PQMIPLRIRFVQJZ-QBYYVRQOSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7